The company
Nutrien Ltd. Common Shares
NTR · NYSE
NTR stood above a rising 150-day average in 35 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 3.7% below that average now. Agricultural Chemicals & Fertilizers: 0% of its 10 stocks in an uptrend (−20 points in four weeks); Materials: 18% (−5 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 4
- Industry in uptrend
- 0% -20 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 9
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 35 of 52 weeks.
Agricultural Chemicals & Fertilizers: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Materials: Few of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
9 disclosed lines: House 5, Senate 2, executive 2; 6 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Arjun Mody Executive branch: Office of Government EthicsSocial Security Administration | sold | $1k–$15k | 30 Jan 2026filed 10 Apr 2026 |
| Val T. Hoyle House: U.S. House ClerkOR04 | soldspouse | $1k–$15k | 23 Sep 2025filed 10 Oct 2025 |
| Christopher Landau Executive branch: Office of Government EthicsDepartment of State | sold | $15k–$50k | 28 Apr 2025filed 16 Jul 2025 |
| Val T. Hoyle House: U.S. House ClerkOR04 | boughtspouse | $1k–$15k | 29 Oct 2024filed 12 Sep 2025 |
| Thomas R. Carper Senate: U.S. Senate eFDSenator | boughtspouse | $1k–$15k | 28 Mar 2024filed 29 Mar 2024 |
| Pete Ricketts Senate: U.S. Senate eFDSenator | soldspouse | $50k–$100k | 21 Sep 2023filed 20 Oct 2023 |
| Dean Phillips House: U.S. House ClerkMN03 | sold | $1k–$15k | 10 Feb 2020filed 12 Mar 2020 |
| Dean Phillips House: U.S. House ClerkMN03 | sold | $1k–$15k | 25 Oct 2019filed 6 Nov 2019 |
| Dean Phillips House: U.S. House ClerkMN03 | sold | $1k–$15k | 4 Apr 2019filed 21 May 2019 |
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.